Testing Healthy Participants for Drowsiness After Single Dosing of Two Different Doses of Muscle Relaxer
A Prospective, Randomized, Single-blind, Study to Assess Drowsiness, Cognition, Fall Risk, and Electroencephalographic (EEG) Dynamics After Oral Metaxalone Tablets 640 mg (M640) Versus Metaxalone 800 mg in Healthy Participants
Health participants take a single dose, perform testing, washout for one week, take a single dose of different formulation, and perform testing for comparison of the 2 doses.
研究概览
详细说明
Healthy participants will take one dose of a drug after eating a meal. When the drug is at the highest level in their blood, testing for drowsiness and the risk of falling will take place. Brain wave monitoring known as an EEG will take place throughout the testing. Participants will take a second dose of the drug with the same testing one week later.
研究类型
注册 (估计的)
阶段
- 第四阶段
联系人和位置
学习联系方式
- 姓名:Project Manager
- 电话号码:480-483-1410
- 邮箱:mshahbandar@primusrx.com
研究联系人备份
- 姓名:Clinical Manager
- 电话号码:480-250-6689
- 邮箱:msanstead@primusrx.com
学习地点
-
-
Ohio
-
Columbus、Ohio、美国、43213
- 招聘中
- AMR Clinical - Columbus
-
接触:
- Site Manager
- 电话号码:614-683-5800
- 邮箱:jim.sanders@amr-clinical.com
-
接触:
- Study Coordinator
- 电话号码:614-683-5800
- 邮箱:kim.burmane@amr-clinical.com
-
首席研究员:
- Harold Green, MD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Healthy adults aged 18 to 55 years old
- Weigh at least 120 pounds
- Medically healthy
- Able to sign and date informed consent form
Exclusion Criteria:
- Current use of any medications known to affect the sleep-wake cycle
- Sleep disorder diagnosis
- Positive urine test for drugs
- Known history of alcohol use disorder
- Having a history of cognitive disorders, depression, schizophrenia, panic disorder, or dementia
- Having difficulty eating high fat meal
- Participants who are pregnant, nursing or intending to become pregnant during the period of study.
- Blood Pressure > 160/110 or <90/50 mmHg.
- Heart Rate >100 or < 50/ beats per minute.
- Having a history of seizure disorder or epilepsy.
学习计划
研究是如何设计的?
设计细节
- 主要用途:基础科学
- 分配:随机化
- 介入模型:交叉作业
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Active metaxalone m640 mg
One dose administered after a standard meal with testing Baseline dose to time of maximum concentration (Tmax) |
Dose micronized 640 mg
其他名称:
|
|
有源比较器:Active metaxalone 800 mg
One dose administered after a standard meal with testing Baseline dose to time of maximum concentration (Tmax) |
The dose is 800 mg
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change from baseline to approximately 4 hours post-dose, in mean reaction time to a stimulus as measured in milliseconds by the Reaction Time Test (RTT)
大体时间:Baseline dose to four (4 ) hours post-dose
|
Measures the time between a visual stimulus and response, measured in milliseconds |
Baseline dose to four (4 ) hours post-dose
|
|
Change from baseline to approximately 4 hours post-dose of delayed response exceeding a predefined threshold >300 ms as measured by the Reaction Time Test (RTT)
大体时间:Baseline dose to approximately 4 hours post-dose
|
measures the time between a visual stimulus and response, measured in milliseconds |
Baseline dose to approximately 4 hours post-dose
|
合作者和调查者
调查人员
- 研究主任:James Lukban, D.O.、Primus Pharmaceutical, Inc.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
No plan for publication at this time.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.